Effective Treatment of Osteomyelitis with Biodegradable Microspheres in a Rabbit Model

Clinical Orthopaedics and Related Research

Volumn 421, Issue , 2004, Pages 293-299

  Ambrose, Catherine G ^a,d   Clyburn, Terry A ^a   Louden, Keith ^a   Joseph, John ^a   Wright, John ^a   Gulati, Poonam ^b   Gogola, Gloria R ^a   Mikos, Antonios G ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF HOUSTON DOWNTOWN   (United States)

^c Rice University   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; CEFAZOLIN; MICROSPHERE; POLY(METHYL METHACRYLATE); POLYGLACTIN; TOBRAMYCIN SULFATE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; PARENTERAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 2342524001     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000126303.41711.a2     Document Type: Article

References (29)

1. Aimin C, Chunlin H, Juliang B, Tinyin Z, Zichao D: Antibiotic loaded chitosan bar: An in vitro, in vivo study of a possible treatment for osteomyelitis. Clin Orthop 366:239-247, 1999.
2. Ambrose CG, Gogola GR, Clyburn TA, et al: Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis. Clin Orthop 415:279-285, 2003.
3. Brien WW, Salvati EA, Klein R, et al: Antibiotic impregnated bone cement in total hip arthroplasty: An in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop 296:242-248, 1993.
4. Buchholz HW, Engelbrecht H: Chirurg 41:511-515, 1970. ([Depot effects of various antibiotics mixed with palacos resins])
5. Calhoun JH, Mader JT: Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin Orthop 341:206-214, 1997.
6. Cleek RL, Ting KC, Eskin SG, Mikos AG: Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J Contr Release 48:259-268, 1997.
7. Dirschl DR, Almekinders LC: Osteomyelitis: Common causes and treatment recommendations. Drugs 45:29-43, 1993.
8. Garvin KL, Miyano JA, Robinson D, et al: Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis: A canine model. J Bone Joint Surg 76A: 1500-1506, 1994.
9. Hickmon SG, Skinner RA, Nelson CL, et al: Efficacy of treatment of experimental osteomyelitis with calcium sulfate pellets containing tobramycin. The Forty-Fourth Annual Meeting of the Orthopaedic Research Society. New Orleans, LA 427, 1998.
10. Jacob E, Cierny G, Zorn K, McNeill JF, Fallon MT: Delayed local treatment of rabbit tibial fractures with biodegradable cefazolin microspheres. Clin Orthop 336:278-285, 1997.
11. Kanellakopoulou K, Giamarellos-Bourboulis E: Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59:1223-1232, 2000.
12. Lew DP, Waldvogel FA: Osteomyelitis. N Engl J Med 336:999-1007, 1997.
13. Liu S-J, Ueng SW-N, Chan EC, et al: In vitro elution of vancomycin from biodegradable beads. J Biomed Mater Res 48:613-620, 1999.
14. Mader JT, Landon GC, Calhoun J: Antimicrobial treatment of osteomyelitis. Clin Orthop 295:87-95, 1993.
15. Masri BA, Duncan CP, Beauchamp CP: Long-term elution of antibiotics from bone cement: An in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 13:331-338, 1998.
16. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard NCCLS Document M7-A4 17:1997.
17. Nie L, Nicolau DP, Tessier PR, et al: Use of a bioabsorbable polymer for the delivery of ofloxin during experimental osteomyelitis treatment. J Orthop Res 16:76-79, 1998.
18. Nijhof MW, Dhert WJA, Fleer A, Vodely HC, Verbout AJ: Prophylaxis of implant-replated staphylococcal infections using tobramycin-containing bone cement. J Biomed Mater Res 52:754-761, 2000.
19. Nijhof MW, Fleer A, Haruds K, et al: Tobramycin-containing bone cement and systemic cefazolin in a one-stage revision: Treatment of infection in a rabbit model. J Biomed Mater Res 58:747-753, 2001.
20. Nijhof MW, Stallmann HP, Vogely HC, et al: Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model. J Biomed Mater Res 52:709-715, 2000.
21. Overbeck JP, Winckler ST, Meffert R, et al: Penetration of ciprofloxin into bone: A new bioabsorbable implant. J Invest Surg 8:155-162, 1995.
22. Penner MJ, Duncan CP, Masri BA: The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R cements. J Arthroplasty 14:209-214, 1999.
23. Richelsoph KC, Peterson DW, Haggard WO, Grisoni BF, Morris LH: Elution characteristics of tobramycin-impregnated medical grade calcium sulfate hemihydrate. The Forty-Fourth Annual Meeting of the Orthopaedic Research Society. New Orleans, LA 429, 1998.
24. Smeltzer MS, Thomas JR, Hickmon SG, et al: Characterization of a rabbit model of staphylococcal osteomyelitis. J Orthop Res 15:414-421, 1997.
25. Solberg BD, Gutow AP, Baumgaertner MR: Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 13:102-106, 1999.
26. Ueng S, Lee S, Lin S, et al: Biodegradable alginate antibiotic beads. Clin Orthop 380:250-259, 2000.
27. Wachol-Drewek Z, Pfeiffer M, Scholl E: Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 17:1733-1738, 1996.
28. Walenkamp GH: Osteomyelitis. Gentamicin-PMMA Beads: A Clinical, Pharmacokinetic and Toxicological Study. Amsterdam, Drukkerij Cliteur 19-22, 1983.
29. Wang J, Calhoun JH, Mader JT, LeFrock J: The Role and Effectiveness of Adjunctive Therapy in the Management of Musculoskeletal Infections. In Calhoun JH, Mader JT (eds). Musculoskeletal Infections. New York, Marcel Dekker 555-585, 2003.